© Fraunhofer

The Mission of Fraunhofer Chile Research

© Fraunhofer

Overview

• What is the Fraunhofer Gesellschaft

• What is Fraunhofer Chile Research

• What do we do in the Centre for Systems Biotechnology

• How do we address Intellectual Property development

© Fraunhofer

Fraunhofer Gesellschaft

• Largest Applied Research Organisation in Europe

• 60 Institutes focussed on applied research

• 18000 employees

• Budget over 1.7bil Euros

• Over 1.4bil Euros in contract research funding

• Income from Industry 1.05bil Euros

• Supports Innovation for German Industry

• Institutes cover all aspects of industrial landscape

• Extensive IP estate and licensing income

© Fraunhofer

Institute Alliances Themes •Microelectronics

•Production

•Information, Communication

•Materials and Components

•Surface technology, Photonics

•Defense research

•Life Sciences

• Health

• Security

• Communication

• Mobility

• Energy

• Environment

© Fraunhofer

Applied Research

• Applied Research helps Industry with Innovation

• Focus on Industry needs

• Diverse range of projects ( single to multiple partners, to large international networks)

• Internal research develops leading edge platform technologies which allow industry to develop innovative products

• IP Development and protection is key to competitive advantage

© Fraunhofer

Applications at the German Patent and Trade Mark Office

Source: German

Patent

and Trade Mark

Office

ZV-P2/Mai 2009

1 236DEInf ineon Technologies AG4

1 626DEDaimlerChrysler AG3

2 202DERobert Bosch GmbH2

2 501DESiemens AG1

621DEBayerische Motoren Werke AG8

690DEBASF AG7

708JPDenso Corp.6

731DEVolkswagen AG5

382DEBSH Bosch Siemens Hausgeräte

GmbH

12

396DEFraunhofer-Gesellschaft11

411DEAudi AG10

545DEZF Friedrichshafen AG9

335DEVoith Patent GmbH14

371DESchaef f ler KG13

265DEHenkel KGaA15

...

ApplicantsCountryApplicantRanking

1 236DEInf ineon Technologies AG4

1 626DEDaimlerChrysler AG3

2 202DERobert Bosch GmbH2

2 501DESiemens AG1

621DEBayerische Motoren Werke AG8

690DEBASF AG7

708JPDenso Corp.6

731DEVolkswagen AG5

382DEBSH Bosch Siemens Hausgeräte

GmbH

12

396DEFraunhofer-Gesellschaft11

411DEAudi AG10

545DEZF Friedrichshafen AG9

335DEVoith Patent GmbH14

371DESchaef f ler KG13

265DEHenkel KGaA15

...

ApplicantsCountryApplicantRanking

© Fraunhofer

Strategy

• Fraunhofer activities are closely linked to National Innovation Strategies

• Internal analysis of both national and international industry trends

• Close links with Universities provide reach into basic research and future technologies

• Constantly changing project portfolios provide adaptability to react to industries needs

© Fraunhofer

Identification of Novel Innovation Potentials Early On

Foresight analyses and trend studies

50 Technology- trends

Workshop with >50 experts

Perspec

-tives

2004 2005

1. consultation:

Fh-leaders 170 topics

2. consultation: Topic-ranking

Expert interviews: 25 Focus-topics

Future

Topics

2007 2008

Global Megatrends

12 12

Grand societal challenges

Technology based problem solutions

Mapping

Fh-competences

Fraunhofer-

internal process

Tomorrow

Markets

2010 2011

5

Perspectives for

Future Markets

Fraunhofer

Frontline Themes Markets for

tomorrow

© Fraunhofer

Fraunhofer Chile Research

• FCR established in 2010 as a Foundation

• Aim is to channel Fraunhofer Innovation Model to Chile and other South American Countries

• Centre for Systems Biotechnology is first activity

• Contribute to exchange of technologies and personnel between Germany and Chile

• Contribute to technical and human resources capacity development in Chile

• Closely linked to Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)

Mission:

Develop and apply cutting edge enabling technologies to assist

the diagnosis and treatment of human and animal diseases and

to protect food and feed stocks around the world

IME Molecular Biology Aachen

Avia-Luftbild, Aachen – Dipl.-Ing. Martin Jochum

Fraunhofer IME

Locations in Aachen, RWTH Aachen, Giessen, Muenster,

Schmallenberg, Neustadt, USA

Total funds raised over Euro M200

365 staff members (2009)

Budget 40 M Euro (2010)

37% Industry revenue

Large patent estate through in-house activities and

collaborative projects

IME Business Fields Applied and functional genomics (target identification)

Pharmaceutical product development (antibodies, vaccines)

integrated production platforms

Plant biotechnology

Industrial biotechnology

Insect biotechnology

Systems biotechnology

Ecotoxicology

Regulatory support

© Fraunhofer

Center for Systems Biotechnology

© Fraunhofer

Center for Systems Biotechnology

All Partners

Platform Technologies

FC/IME

Aquaculture PUCV/IME

EnergyUTalca/IME

Agriculture

Corporate Management Unit

© Fraunhofer

Center for Systems Biotechnology

• CSB established under International Centre of Excellence (ICE) umbrella.

• Funding provided by INNOVACorfo in Chile and Fraunhofer Gesellschaft in Germany

• Chilean partners and IME make significant in kind contributions

• Expected budget approximately $50Mil for 10 years

• Major focus on IP generation and exploitation

© Fraunhofer

Center for Systems Biotechnology

• Collaboration between IME staff and Chilean scientist

• Chilean contingent composed of FCR-CSB internal staff and collaborating co-executors scientists

• Over 40 employees by end of 2011

• Over 35 partner employees dedicated to projects

• Over 20 IME employees dedicated to projects

• Development of platform technologies for innovation

• Developing contacts with industry to identify real needs

© Fraunhofer

Center for Systems Biotechnology

Aquaculture

• Collbaroation with Fundacion Chile

• Novel Vaccine Development for salmon disease

• Using IME Production Platform in plants cells

• Markers for early disease detection

• Novel molecular approaches

• Application of technologies to other fish species

• Hake, sea bass,

© Fraunhofer

Center for Systems Biotechnology

Bioenergy

• Collaboration with PUCV

• Development of novel biofuel species

• Microalgae, Jatropha, Russian Dandelion

• Providing enginering solutions for extraction of oils, latex and byproducts from these species

• Life cycle analysis to address sustainability issues

© Fraunhofer

Center for Systems Biotechnology

Smart Polymers

• Collaboration with Talca University

• Chemical synthesis of smart polymers

• Synthesis driven by rational design derived from computational modelling

• Use of polymers to remove unwanted chemicals in wine and fruit juices

• Database development

© Fraunhofer

Center for Systems Biotechnology

Platform Technologies

• Collaboration with PUCV and U Talca

• Bio-Computing

• Bioinformatics for ´omics technologies

• Modelling

• Increasing capacity

• Peptide synthesis for novel therapeutics

• Increasing synergies between partners

© Fraunhofer

What we want to develop

All Partners

Platform Technologies

FC/IME

Aquaculture PUCV/IME

EnergyUTalca/IME

AgricultureTBC/IME

BiominingTBC/IME

Health

Corporate Management Unit

© Fraunhofer

Centre of Systems Biotechnology

Forms of IP

• Patent protection

• Trade Mark protection

• Design protection

• Copyright rotection

• Trade and industrial secretsts

•

•

© Fraunhofer

Centre of Systems Biotechnology

We will use Trade Secret protection

• In business areas where services are provided

• In areas in of own research

• In areas where relationship with customers determines that this form of protection is appropriate

•

•

© Fraunhofer

Centre of Systems Biotechnology

We will use patent protection

• in key business areas for platform technology development

• when patents are required by customers to improve their business

• to establish new concepts derived from our research

• as a tool in business negotiations

•

•

© Fraunhofer

Centre of Systems Biotechnology

• Value of having a patent is not in dispute as it allows exclusivity to develop products

• Having a patent however is of no value per se, unless its application leads to new product development and new value generation

• Therefore, field of invention, market knowledge and process/product value are key

• Two routes identify the right opportunities

•

•

© Fraunhofer

Routes of IP Generation Two examples from my own life (1)

• Research driven discovery and market creation

• Functional Genomics Research in Tomato

• Development of broad patent portfolio

• Production of novel GM tomato varieties for processing industry

• Identification of commercial benefit of new tomatoes

• Sale of product in UK supermarkets

© Fraunhofer

Routes of IP Generation

Two examples from my own life (2)

• Market driven discovery

• Develop insect/herbicide resistant maize

• Development of broad patent portfolio

• Identify routes to develop resistance

• Test GM plants for insect/herbicide resistance

• Create market for GM maize varieties

© Fraunhofer

Routes of IP Generation

Comparison

• Patenting process identical

• Patenting strategy identical

• Market analysis identical

• Commercial strategies were completely different

• Market driven approach had fewer commercial uncertainties

© Fraunhofer

IP Generation at FCR

• We use both R&D driven and market driven approaches

• For R&D driven process:

• Publication review strategy

• Develop a patenting strategy for broad coverage

• Internal/external background IP review

• Consultation with internal partners for field of application and potential value of invention

• Apply for patent protection in suitable geographies

© Fraunhofer

IP Generation at FCR

• We use both R&D driven and market driven appraoches

• For market driven process:

• Close collaboration with industrial partner

• Internal/external background IP review

• Design a patenting strategy for specific application

• Apply for patent protection in suitable geographies

© Fraunhofer

IP Generation at FCR

• FCR does not have in-house patent agent/s

• However, we do have staff with IP experience

• Carry out training in IP searches, analysis and strategic developments

• We will work with local firms providing IP services well as overseas companies

• FCR/FG owns IP from platform development

• We will share IP depending on level of compensation

© Fraunhofer

IP Generation at FCR

• Publications are key to maintain highest scientific standing

• IP generation will have incentives

• Entrepreneureal culture will be encouraged

• Partnerships with outsid companbies will be encouraged

• Spin-offs will be formed based on the body of IP and market opportunity

© Fraunhofer

Summary

• IP generation is central to FCRs activities

• Platform technology development offers many opportunities for innovation

• Proximity to industry offers many opportunities for applying this IP and developing additional IP

• Strategy development is essential for success

© Fraunhofer

Wolfgang Schuch

General Manager

Fraunhofer Chile Research Foundation

Centre of Systems Biotechnology

Sanches Fonticilla 310, Piso 14

Las Condes, Santiago, Chile

Wolfgang.schuch@fraunhoferchile.cl

56 96 597 9364

Contact Details